时间：2019-05-22 16:00 至 2019-05-24 11:00
会议时间：2019-05-22 16:00至 2019-05-24 11:00结束
会议地点： 上海 详细地址会前通知
|学生代表通票 3天盛会，精品茶歇，全套会刊资料||￥1150.0||2019-05-21 17:00|
|普通代表通票（仅面向医院医护人员与高校及科研院所科研人员） 3天盛会，精品茶歇，全套会刊资料||￥2300.0||2019-05-21 17:00|
|企业代表通票 3天盛会，精品茶歇，全套会刊资料||￥3500.0||2019-05-21 17:00|
Cancer Immunology and Immunotherapy Symposium
22-24th, May 2019, Shanghai, China
It is estimated that there will be 18.1 million new cancer cases (17 million excluding non-melanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding non-melanoma skin cancer) worldwide in 2018. Asia accounts for nearly 50% of the 18.1 million new cancers, while Asia accounts for nearly 70% of the 9.6 million cancer deaths. In China, the incidence of malignant tumors is 270.59/100,000, and the mortality rate is 163.83/100,000. On average, about 10,000 people are diagnosed with cancer every day.
Significant progress has been made in the field of immunology over the past two decades. Therapeutic agents such as anti-TNF, anti-CD20, anti-CTLA4, and more recently anti-PD1 have benefited countless patients. Cancer immunotherapy is now an established field that has led to remarkable clinical benefit for a subset of patients and revolutionized the treatment of many cancer types over the past five years. The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies.
Symposium topics will include innate immunity, cancer vaccines, inflammation, tumor microenvironment & metastasis and so on, which are key to harnessing the immune system to fight cancer and autoimmune diseases.
A primary goal of the meeting is to provide a symposium where medical scientists from academia can interact with clinician and scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for cancer has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia clinician and industry meet regularly to exchange data and ideas.
上海决策者经济顾问股份有限公司（China Decision Makers Consultancy，英文简称：CDMC）成立于2004年，经过12年的历练，已成为亚洲国际会议第一品牌。公司拥有100余人的跨国人才团队，塑造了7个产业群，超过50个具有国际影响力的产业会议品牌，涵盖能源资源、环保基建、交通物流、金融投资、高端消费、医药食品等行业，每年在中国及海外包括日本、印度、新加坡、越南、印尼等国家举办30余场高端国际大会、30余场行业培训、近20场海内外商务考察活动。
The meeting will begin on Wednesday, May 22 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Friday, May 24 with a closing plenary session from 9:00 to 11:10, followed by a social hour and entertainment. We recommend return travel on Friday, May 24 in order to fully experience the meeting.
Keynote speaker （inviting）